Thursday, October 8th, 2015
Glaxosmithkline PLC, the sixth largest pharmaceutical company in the world, a constituent of the FTSE 100 and the fourth largest company on the LSE by market cap, flounders with sustained controversies on unethical marketing and sales, clinical trials and faulty governance practices. Practices that date back to the company’s inception in 2000 and continue irrespective[...] Read moreThursday, October 8th, 2015
OGX, once the second largest Oil and Gas Company in Brazil by market value is now merely a blip in the Oil & Gas industry. Investors could have saved billions of dollars from this stock. How? Through Solaron Research, prepared meticulously using an in-depth understanding of the local & business context and stakeholder inputs on[...] Read moreThursday, October 8th, 2015
As the financial aftershocks of the $17 billion bribery & kickback scandal continue, investors would do well to look back at the tell-tale signs that were all too apparent. Symptoms were diagnosed as early as 2012 that questioned the company’s seriousness and ability to capitalize on the $70 billion IPO and newly discovered deep sea[...] Read more